Article Information
History
- November 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Keri N Althoff1,*,
- Cameron Stewart1,
- Elizabeth Humes1,
- Lucas Gerace1,
- Cynthia Boyd1,2,3,
- Kelly Gebo4,
- Amy C Justice5,6,
- Emily Hyle7,8,
- Sally Coburn1,
- Raynell Lang9,
- Michael J Silverberg10,11,
- Michael Horberg12,
- Viviane D Lima13,
- M John Gill9,
- Maile Karris14,
- Peter F Rebeiro15,
- Jennifer Thorne16,
- Ashleigh J Rich17,
- Heidi Crane18,
- Mari Kitahata18,
- Anna Rubtsova19,
- Cherise Wong20,
- Sean Leng2,
- Vincent C Marconi21,22,
- Gypsyamber D’Souza1,
- Hyang Nina Kim18,
- Sonia Napravnik23,
- Kathleen McGinnis6,
- Gregory D Kirk1,4,
- Timothy R Sterling24,25,
- Richard D Moore26 and
- Parastu Kasaie1
- 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 2Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
- 3Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 4Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
- 5Yale Schools of Medicine and Public Health, New Haven, Connecticut, USA
- 6Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
- 7Harvard Medical School and the Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
- 8Harvard University Center for AIDS Research, Boston, MA, USA
- 9Department of Medicine, University of Calgary, Calgary, Alberta, Canada
- 10Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA and Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA
- 11Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
- 12Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic Permanente Medical Group, Rockville, MD USA
- 13Epidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada
- 14Department of Medicine, University of California San Diego, San Diego, CA, USA
- 15Departments of Medicine and Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA
- 16Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 17Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA
- 18Division of Allergy and Infectious Diseases, Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, USA
- 19Department of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, GA, USA
- 20Division of Worldwide Research and Development, Pfizer Inc., New York, NY, USA
- 21Division of Infectious Disease, Emory School of Medicine, Atlanta, GA, USA
- 22Atlanta Veterans Affairs Health Care System, Decatur, GA, USA
- 23Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 24Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
- 25Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
- 26Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
- ↵*Corresponding author:
Keri N Althoff, PhD, MPH, Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St., Rm E7142, Baltimore, MD, 21205, kalthoff{at}jhu.edu
Posted November 05, 2022.
The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030
